BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36638597)

  • 1. Recent advances in magnetic nanocarriers for tumor treatment.
    Zhu J; Wang J; Li Y
    Biomed Pharmacother; 2023 Mar; 159():114227. PubMed ID: 36638597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms.
    Chen X; Lei S; Lin J; Huang P
    Expert Opin Drug Deliv; 2022 Nov; 19(11):1487-1504. PubMed ID: 36214740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications.
    Wu W; Luo L; Wang Y; Wu Q; Dai HB; Li JS; Durkan C; Wang N; Wang GX
    Theranostics; 2018; 8(11):3038-3058. PubMed ID: 29896301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics.
    Vangijzegem T; Stanicki D; Laurent S
    Expert Opin Drug Deliv; 2019 Jan; 16(1):69-78. PubMed ID: 30496697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox Nano-Architectures: Perspectives and Implications in Diagnosis and Treatment of Human Diseases.
    Sufi SA; Pajaniradje S; Mukherjee V; Rajagopalan R
    Antioxid Redox Signal; 2019 Feb; 30(5):762-785. PubMed ID: 29334759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy.
    Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
    Life Sci; 2022 Dec; 310():121133. PubMed ID: 36306866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.
    Agiba AM; Arreola-Ramírez JL; Carbajal V; Segura-Medina P
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors.
    Din FU; Aman W; Ullah I; Qureshi OS; Mustapha O; Shafique S; Zeb A
    Int J Nanomedicine; 2017; 12():7291-7309. PubMed ID: 29042776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics.
    Mi P
    Theranostics; 2020; 10(10):4557-4588. PubMed ID: 32292515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internal stimuli-responsive nanocarriers for controlled anti-cancer drug release: a review.
    Shaik BB; Katari NK; Jonnalagadda SB
    Ther Deliv; 2023 Sep; 14(9):595-613. PubMed ID: 37877308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Application of Stimuli-responsive Nanocarriers for Targeted Drug Delivery.
    Zhou M; Wen K; Bi Y; Lu H; Chen J; Hu Y; Chai Z
    Curr Top Med Chem; 2017; 17(20):2319-2334. PubMed ID: 28240179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles.
    Souri M; Soltani M; Moradi Kashkooli F; Kiani Shahvandi M
    J Control Release; 2022 Jan; 341():227-246. PubMed ID: 34822909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy.
    Ashrafizadeh M; Zarrabi A; Bigham A; Taheriazam A; Saghari Y; Mirzaei S; Hashemi M; Hushmandi K; Karimi-Maleh H; Nazarzadeh Zare E; Sharifi E; Ertas YN; Rabiee N; Sethi G; Shen M
    Med Res Rev; 2023 Nov; 43(6):2115-2176. PubMed ID: 37165896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting.
    Tian X; Shi A; Wu J
    Anticancer Agents Med Chem; 2022; 22(12):2255-2273. PubMed ID: 34994336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
    Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
    Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
    Ge Z; Liu S
    Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications.
    Handa M; Singh A; Flora SJS; Shukla R
    Curr Pharm Des; 2022; 28(11):910-921. PubMed ID: 34879797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-responsive (nano)architectures for phytochemical delivery in cancer therapy.
    Zandieh MA; Farahani MH; Daryab M; Motahari A; Gholami S; Salmani F; Karimi F; Samaei SS; Rezaee A; Rahmanian P; Khorrami R; Salimimoghadam S; Nabavi N; Zou R; Sethi G; Rashidi M; Hushmandi K
    Biomed Pharmacother; 2023 Oct; 166():115283. PubMed ID: 37567073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.